BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32975514)

  • 1. POMK regulates dystroglycan function via LARGE1-mediated elongation of matriglycan.
    Walimbe AS; Okuma H; Joseph S; Yang T; Yonekawa T; Hord JM; Venzke D; Anderson ME; Torelli S; Manzur A; Devereaux M; Cuellar M; Prouty S; Ocampo Landa S; Yu L; Xiao J; Dixon JE; Muntoni F; Campbell KP
    Elife; 2020 Sep; 9():. PubMed ID: 32975514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal domain on dystroglycan enables LARGE1 to extend matriglycan on α-dystroglycan and prevents muscular dystrophy.
    Okuma H; Hord JM; Chandel I; Venzke D; Anderson ME; Walimbe AS; Joseph S; Gastel Z; Hara Y; Saito F; Matsumura K; Campbell KP
    Elife; 2023 Feb; 12():. PubMed ID: 36723429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma.
    Beltrán D; Anderson ME; Bharathy N; Settelmeyer TP; Svalina MN; Bajwa Z; Shern JF; Gultekin SH; Cuellar MA; Yonekawa T; Keller C; Campbell KP
    Skelet Muscle; 2019 May; 9(1):11. PubMed ID: 31054580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HNK-1 sulfotransferase modulates α-dystroglycan glycosylation by 3-O-sulfation of glucuronic acid on matriglycan.
    Sheikh MO; Venzke D; Anderson ME; Yoshida-Moriguchi T; Glushka JN; Nairn AV; Galizzi M; Moremen KW; Campbell KP; Wells L
    Glycobiology; 2020 Sep; 30(10):817-829. PubMed ID: 32149355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of protein O-mannose kinase reveals a unique active site architecture.
    Zhu Q; Venzke D; Walimbe AS; Anderson ME; Fu Q; Kinch LN; Wang W; Chen X; Grishin NV; Huang N; Yu L; Dixon JE; Campbell KP; Xiao J
    Elife; 2016 Nov; 5():. PubMed ID: 27879205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D structural analysis of protein O-mannosyl kinase, POMK, a causative gene product of dystroglycanopathy.
    Nagae M; Mishra SK; Neyazaki M; Oi R; Ikeda A; Matsugaki N; Akashi S; Manya H; Mizuno M; Yagi H; Kato K; Senda T; Endo T; Nogi T; Yamaguchi Y
    Genes Cells; 2017 Apr; 22(4):348-359. PubMed ID: 28251761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding.
    Yoshida-Moriguchi T; Yu L; Stalnaker SH; Davis S; Kunz S; Madson M; Oldstone MB; Schachter H; Wells L; Campbell KP
    Science; 2010 Jan; 327(5961):88-92. PubMed ID: 20044576
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Yonekawa T; Rauckhorst AJ; El-Hattab S; Cuellar MA; Venzke D; Anderson ME; Okuma H; Pewa AD; Taylor EB; Campbell KP
    Sci Adv; 2022 May; 8(21):eabn0379. PubMed ID: 35613260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues.
    Inamori K; Willer T; Hara Y; Venzke D; Anderson ME; Clarke NF; Guicheney P; Bönnemann CG; Moore SA; Campbell KP
    J Biol Chem; 2014 Oct; 289(41):28138-48. PubMed ID: 25138275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Modeling of a GT-A Fold in the α-Dystroglycan Glycosylating Enzyme LARGE1.
    Righino B; Bozzi M; Pirolli D; Sciandra F; Bigotti MG; Brancaccio A; De Rosa MC
    J Chem Inf Model; 2020 Jun; 60(6):3145-3156. PubMed ID: 32356985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function.
    Yoshida-Moriguchi T; Willer T; Anderson ME; Venzke D; Whyte T; Muntoni F; Lee H; Nelson SF; Yu L; Campbell KP
    Science; 2013 Aug; 341(6148):896-9. PubMed ID: 23929950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane.
    Yoshida-Moriguchi T; Campbell KP
    Glycobiology; 2015 Jul; 25(7):702-13. PubMed ID: 25882296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Matriglycan by Dual Exoglycosidase Digestion of α-Dystroglycan.
    Chandel I; Campbell KP
    Bio Protoc; 2023 Sep; 13(18):e4827. PubMed ID: 37753476
    [No Abstract]   [Full Text] [Related]  

  • 14. Mouse large can modify complex N- and mucin O-glycans on alpha-dystroglycan to induce laminin binding.
    Patnaik SK; Stanley P
    J Biol Chem; 2005 May; 280(21):20851-9. PubMed ID: 15788414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscular dystrophy-dystroglycanopathy in a family of Labrador retrievers with a LARGE1 mutation.
    Shelton GD; Minor KM; Guo LT; Friedenberg SG; Cullen JN; Hord JM; Venzke D; Anderson ME; Devereaux M; Prouty SJ; Handelman C; Campbell KP; Mickelson JR
    Neuromuscul Disord; 2021 Nov; 31(11):1169-1178. PubMed ID: 34654610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycan.
    Kuwabara N; Manya H; Yamada T; Tateno H; Kanagawa M; Kobayashi K; Akasaka-Manya K; Hirose Y; Mizuno M; Ikeguchi M; Toda T; Hirabayashi J; Senda T; Endo T; Kato R
    Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9280-5. PubMed ID: 27493216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of post-phosphoryl modification in dystroglycanopathy mouse models and wild-type tissues expressing non-laminin binding form of α-dystroglycan.
    Kuga A; Kanagawa M; Sudo A; Chan YM; Tajiri M; Manya H; Kikkawa Y; Nomizu M; Kobayashi K; Endo T; Lu QL; Wada Y; Toda T
    J Biol Chem; 2012 Mar; 287(12):9560-7. PubMed ID: 22270369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycomic analyses of mouse models of congenital muscular dystrophy.
    Stalnaker SH; Aoki K; Lim JM; Porterfield M; Liu M; Satz JS; Buskirk S; Xiong Y; Zhang P; Campbell KP; Hu H; Live D; Tiemeyer M; Wells L
    J Biol Chem; 2011 Jun; 286(24):21180-90. PubMed ID: 21460210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a short, single site matriglycan that maintains neuromuscular function in the mouse.
    Yang T; Chandel I; Gonzales M; Okuma H; Prouty SJ; Zarei S; Joseph S; Garringer KW; Landa SO; Yonekawa T; Walimbe AS; Venzke DP; Anderson ME; Hord JM; Campbell KP
    bioRxiv; 2023 Dec; ():. PubMed ID: 38187633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. POMK mutations disrupt muscle development leading to a spectrum of neuromuscular presentations.
    Di Costanzo S; Balasubramanian A; Pond HL; Rozkalne A; Pantaleoni C; Saredi S; Gupta VA; Sunu CM; Yu TW; Kang PB; Salih MA; Mora M; Gussoni E; Walsh CA; Manzini MC
    Hum Mol Genet; 2014 Nov; 23(21):5781-92. PubMed ID: 24925318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.